Literature DB >> 31363726

Cordyceps militaris polysaccharides exerted protective effects on diabetic nephropathy in mice via regulation of autophagy.

Dan-Dan Chen1, Rui Xu, Jiu-Yao Zhou, Jun-Qi Chen, Lin Wang, Xu-Sheng Liu, Chun-Ling Liang, Bi-Hao Liu, Rui-Rui Lu, Jun-Biao Wu, Hua Lin.   

Abstract

The present study was designed to investigate the protective effects of Cordyceps militaris polysaccharides (CMP) on STZ-treated DN mice. CMP were identified by FT-IR and HPLC. Diabetic nephropathy (DN) was induced in male C57BL/6 mice by the injection of streptozotocin (STZ, 50 mg kg-1) in citrate buffer on 5 consecutive days. Administration of CMP at 200 and 400 mg kg-1 or irbesartan at 60 mg kg-1 in the STZ-treated mice could prevent the damage caused by STZ. CMP significantly reduced the STZ-induced higher expression of the kidney index, TC, TG, MDA, urinary protein, Scr, and BUN, while it markedly increased the STZ-induced decrease in GSH levels compared with the DN group. Histopathology analysis of the kidney by PAS, Masson, and HE staining confirmed the renal injury induced by STZ and the protective effects of CMP. Transmission electron microscopy (TEM) results confirmed the severe foot process effacement induced by STZ, but CMP treatment inhibited the podocytes' structure defects and ameliorated the function of podocytes. Desmin was measured by immunofluorescence and was related to podocyte injury. The results showed that CMP lessened the expression of desmin induced by STZ. CD68 expression was measured by immunohistochemistry analysis, and the expressions of IL-1β, IL-6, and MCP-1 mRNA were measured by qRT-PCR. The results showed that CMP suppressed the expressions of CD68, IL-1β, IL-6, and MCP-1 mRNA induced by STZ. The role of autophagy in the treatment of DN mice with CMP was detected by TEM and western blotting. The results showed that the administration of CMP was able to overcome the STZ-treated autophagy deficiency, significantly increase the rate of autophagy in the kidney, promote the expression of Atg5, beclin1 and LC3 protein, and reduce the expression of p62 protein. In conclusion, the present study demonstrates that CMP exert a protective effect on DN in STZ-treated mice possibly via activation of autophagy.

Entities:  

Year:  2019        PMID: 31363726     DOI: 10.1039/c9fo00957d

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

Review 1.  Structural Elucidation and Activities of Cordyceps militaris-Derived Polysaccharides: A Review.

Authors:  Miao Miao; Wen-Qian Yu; Yuan Li; Yan-Long Sun; Shou-Dong Guo
Journal:  Front Nutr       Date:  2022-05-31

Review 2.  Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products.

Authors:  Wei Tan; Yunyan Wang; Hongmei Dai; Junhui Deng; Zhifen Wu; Lirong Lin; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 3.  The critical role of dysregulated autophagy in the progression of diabetic kidney disease.

Authors:  Ziwei Zhang; Yuting Sun; Jiaojiao Xue; Xiangyan Li; Daqing Zhao; Fengmei Lian; Wenxiu Qi; Xiaolin Tong
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

4.  Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Authors:  Ming-Fei Guo; Ya-Ji Dai; Jia-Rong Gao; Pei-Jie Chen
Journal:  J Diabetes Res       Date:  2020-03-02       Impact factor: 4.011

5.  Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.

Authors:  Yan Li; Lei Wang; Bojun Xu; Liangbin Zhao; Li Li; Keyang Xu; Anqi Tang; Shasha Zhou; Lu Song; Xiao Zhang; Huakui Zhan
Journal:  J Diabetes Res       Date:  2021-02-05       Impact factor: 4.011

6.  Alginate oligosaccharide alleviates D-galactose-induced cardiac ageing via regulating myocardial mitochondria function and integrity in mice.

Authors:  Wenjing Feng; Jianya Liu; Shan Wang; Yi Hu; Hui Pan; Ting Hu; Huashi Guan; Dongfeng Zhang; Yongjun Mao
Journal:  J Cell Mol Med       Date:  2021-07-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.